siTools Biotech
Private Company
Total funding raised: $2.5M
Overview
siTOOLs Biotech is a privately held, revenue-generating tools and services company operating in the RNA research and genomics sector. Its core technology platform revolves around designing highly specific, complex pools of oligonucleotides (siRNAs and rRNA probes) to enable efficient gene silencing and sample preparation for next-generation sequencing. With a global distributor network and a product portfolio validated in high-impact publications, the company is positioned as a specialized provider for the growing functional genomics and RNA therapeutics research market. Its business model is based on the sale of research-use-only kits and custom services, not therapeutic development.
Technology Platform
Proprietary bioinformatics platform for designing complex, highly specific oligonucleotide pools for gene silencing (siPOOLs) and ribosomal RNA depletion (riboPOOLs), adaptable to any gene or species.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
siTOOLs competes in the research tools segment against giants like Thermo Fisher (Dharmacon), Horizon Discovery, and Qiagen, as well as numerous NGS library prep specialists. Its differentiation is its focus on complex, bioinformatically optimized pools for specificity and its customizability for non-standard research applications, a niche larger players often overlook.